NCT05856422

Brief Summary

The purpose of this study is to conduct a Respiratory Rate accuracy validation on pediatrics population comparing the Gabi SmartCare Gabi Band to the Reference, an FDA cleared End Tidal Carbon Dioxide monitor (GE Datex- Ohmeda) by manually scoring the collected waveform for data analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 5, 2022

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 4, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 12, 2023

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

November 26, 2024

Completed
Last Updated

November 26, 2024

Status Verified

November 1, 2024

Enrollment Period

24 days

First QC Date

May 4, 2023

Results QC Date

October 2, 2024

Last Update Submit

November 18, 2024

Conditions

Keywords

respiratory rate

Outcome Measures

Primary Outcomes (1)

  • Accuracy of Device Under Test for the Measurement of Respiratory Rate, Measured in Breath/Min

    Arms or rms error, given in breath per minute, is the calculation of root mean square between Respiratory rate of the subject device and the manually scored reference Respiratory Rate EtCO2 waveform, for all stable respiratory periods. It is a way of averaging the absolute values of errors over the full measurement range and is a similar measurement to a "rms error". It indicates how far (accurate) the provided value is from the reference used. A passing result required an Arms of ≤3 breaths/min.

    Every 60 seconds, over a total duration of maximum 60 minutes

Study Arms (1)

Pediatrics population

EXPERIMENTAL
Device: Respiratory rate measure based on PPG

Interventions

Testing was conducted under normal office environment conditions. Each subject was connected to the reference EtCO2 monitor (GE Datex-Ohmeda) and the Device Under Test, the Gabi SmartCare Gabi Band. A waveform collected from an EtCO2 measurement was used to determine performance of respiratory rate metrics. Each subject was given a nasal cannula that allowed for measurement of the EtCO2 respiratory rate. The reference respiratory rate was measured simultaneously with the Device Under Test. Data was marked for stable quiet periods that were useable for analysis.

Pediatrics population

Eligibility Criteria

Age1 Minute - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Ability of the parent or guardian to understand and provide written informed consent
  • Participant is 0 to 12 years of age
  • Subjects that are between 7 and 12 years of age must provide Assent to participate in the study

You may not qualify if:

  • Participants evaluated by the Investigator and Clinical Staff and found to be medically unsuitable or have self-reported health conditions that are currently unstable as identified in the Participant Demographics and Screening Record Form
  • Participant has injuries, deformities or abnormalities that may prevent proper application of the device under test
  • Participants with severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors, ECG electrodes, or other medical sensors (self-reported)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinimark LLC

Louisville, Colorado, 80027, United States

Location

Results Point of Contact

Title
Associate Researcher
Organization
Clinimark

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2023

First Posted

May 12, 2023

Study Start

December 5, 2022

Primary Completion

December 29, 2022

Study Completion

December 29, 2022

Last Updated

November 26, 2024

Results First Posted

November 26, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations